CAW
PCRX icon

Cornerstone Advisors (Washington)’s Pacira BioSciences PCRX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2K Hold
28
– – ﹤0.01% 595
2020
Q2 		$1K Buy
+28
New +$1.17K ﹤0.01% 664
2020
Q1 		– Sell
-48
Closed -$2K – 804
2019
Q4 		$2K Buy
48
+8
+20% +$340 ﹤0.01% 604
2019
Q3 		$2K Hold
40
– – ﹤0.01% 602
2019
Q2 		$2K Hold
40
– – ﹤0.01% 1169
2019
Q1 		$2K Buy
+40
New +$1.56K ﹤0.01% 1039

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cornerstone Advisors (Washington)'s PCRX Position: Q3 2020 in Review

Cornerstone Advisors (Washington) held its Pacira BioSciences (PCRX) position steady in Q3 2020 at 28 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Cornerstone Advisors (Washington) first reported a position in PCRX in Q1 2019 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold PCRX as of Q3 2020.

  • Cornerstone Advisors (Washington) held 28 shares of Pacira BioSciences worth $2K as of Q3 2020.
  • Cornerstone Advisors (Washington) left its Pacira BioSciences share count unchanged in Q3 2020.
  • Pacira BioSciences made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #595 holding.
  • Cornerstone Advisors (Washington) first reported a position in Pacira BioSciences in Q1 2019 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.